SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009236
Filing Date
2017-05-08
Accepted
2017-05-08 07:30:24
Documents
100
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hznp-10q_20170331.htm 10-Q 2884323
2 EX-31.1 hznp-ex311_1098.htm EX-31.1 15934
3 EX-31.2 hznp-ex312_1097.htm EX-31.2 15820
4 EX-32.1 hznp-ex321_1095.htm EX-32.1 9300
5 EX-32.2 hznp-ex322_1096.htm EX-32.2 9321
  Complete submission text file 0001564590-17-009236.txt   11792358

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hznp-20170331.xml EX-101.INS 2487641
7 XBRL TAXONOMY EXTENSION SCHEMA hznp-20170331.xsd EX-101.SCH 100687
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20170331_cal.xml EX-101.CAL 60091
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20170331_def.xml EX-101.DEF 438641
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20170331_lab.xml EX-101.LAB 677391
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20170331_pre.xml EX-101.PRE 601689
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 17820579
SIC: 2834 Pharmaceutical Preparations